Pay in 4 interest-free payments of $6.26 Learn more
Ships within 48 hours · Estimated delivery Oct 14 - Oct 19
The brand's published materials reference a clinical study (Sost MM et al., Nutrients, 2021) showing that MicrobiomeX intake was associated with shifts in the microbiome toward butyrate-producing bacterial populations
Mechanism of Action: Research suggests it promotes angiogenesis (new blood vessel formation), collagen synthesis, and cellular signaling pathways that accelerate recovery
No Published Human Trials: There are no robust, large-scale human clinical trials showing BPC 157 can safely induce or maintain clinical remission in IBD
It's so effective
2026 Regulatory Update: On April 15, 2026 the FDA removed both BPC-157 and TB-500 from its Category 2 restricted list
We encourage researchers to stay up-to-date on the latest research regarding 5-amino-1MQ and NNMT blockers
US$ 20.60
US$ 20.24
US$ 27.03
US$ 28.75
US$ 26.14
US$ 21.63
US$ 22.75
